2025-11-15T18:09:06+00:00 2024-12-31 135381590 BDO USA 8401 GREENSBORO DR STE 800 MCLEAN VA 221023599 990 2024-01-01 311621592 INTERNATIONAL VACCINE INSTITUTE INTE 8228722803 1 GWANAK-RO GWANAK-GU SEOUL KS FRANCOIS BELIN DEP DIR GENERAL, COO 7038930600 2025-11-16 true JAKE COOK P01240455 7038930600 2025-11-15 2024 2025-03-06 01:10:19Z JEROME H KIM 1 GWANAK-RO GWANAK-GU SEOUL KS 68966984 false X WWW.IVI.INT X 1997 KS TO DISCOVER, DEVELOP AND DELIVER SAFE, EFFECTIVE AND AFFORDABLE VACCINES FOR GLOBAL PUBLIC HEALTH. ITS VISION IS DEVELOPING COUNTRIES FREE OF SUFFERING FROM INFECTIOUS DISEASE. 20 19 260 21 0 88351550 69619170 0 1740857 1777568 6490073 -2429754 96582480 68966984 28723260 29704558 0 20028787 22804866 0 37081 28929969 21741501 77682016 74250925 18900464 -5283941 104790256 101596804 5152214 7004180 99638042 94592624 X SEE SCHEDULE O false false 2380095 1578883 0 THE PHASE II COMPONENT OF THE STUDY IS COMPLETED, AND THE INTERIM CLINICAL STUDY REPORT (CSR) FROM PHASE II (PARTS A AND B) IS AVAILABLE. BASED ON ADDITIONAL TESTING RESULTS OF DAYS 28 AND 56 OF PHASE 2 SUBGROUP SAMPLES, DATA FROM NHP PASSIVE TRANSFER STUDY, AND SAFETY DATA, A FINAL DECISION ON THE OPTIMAL DOSE FOR PART C WAS MADE, AND 40 UG WAS SELECTED. A CONSORTIUM CONSENSUS JUSTIFICATION MEMO OF FINAL DOSE SELECTION IS COMPLETED. PROTOCOL AMENDMENT V 5.0 CONTAINING THIS NEW INFORMATION WAS APPROVED BY LOCAL ECS AND NRAS. VIRTUAL PI MEETINGS WITH ALL SITES TO UPDATE PROGRAM STATUS AND PROJECTION OF PART C START DATE WERE PERFORMED. A NEW VERSION OF THE INVESTIGATOR BROCHURE (IB) WAS RELEASED IN FEBRUARY 2024. AN AD HOC DSMB MEETING THAT AIMED TO REVIEW IN MORE DETAIL THE PREGNANCIES CASES THAT OCCURRED IN THE PHASE 2 CLINICAL TRIAL IN FEBRUARY 2024. NO SAFETY CONCERNS WERE FOUND IN THE REPORTED DATA. THE START OF ENROLMENT FOR PART C IS NOW PLANNED IN Q3 2025 DUE TO CHANGES IN THE IP MANUFACTURING PROCESS (FROM CELL STACKS TO BIOREACTORS) AND SPONSORSHIP CHANGES FROM IVI TO BHARAT GCCDP 2 CLINICAL TRIAL PROTOCOL SUMMARIES (INCLUDING CHILDREN AND IMMUNOSUPPRESSED POPULATION) WERE PRESENTED TO CEPI DURING THE BID DEFENSE MEETING HELD IN LONDON IN FEBRUARY 2024 1680920 1476583 0 BPCOV2 PROJECT - 2024 SUMMARY OF ACTIVITIES (REFERENCE YEAR 2024) IN 2024, THE BPCOV2 PROJECT ADVANCED PRE-CLINICAL DEVELOPMENT OF A NEXT-GENERATION PAN-CORONAVIRUS MRNA VACCINE PLATFORM SUPPORTED BY CEPI. PROJECT PARTNERS (UPENN, UNC, UC DAVIS, CHULA VRC, AND IVI) FOCUSED ON MRNA CONSTRUCT DESIGN AND PRODUCTION. MULTIPLE MRNA CONSTRUCTS WERE PRODUCED AND TESTED, INCLUDING SPIKE VARIANTS, CHIMERIC CONSTRUCTS, AND VLP PLATFORMS, FORMULATED WITH SM-102 TO ENABLE PLATFORM COMPARISON. 1507443 828050 0 VAT0008 IS A PIVOTAL MULTI-COUNTRY PHASE 3, MULTI-STAGE, MODIFIED DOUBLE-BLIND AND MULTI-ARM STUDY WHERE EFFICACY, SAFETY AND IMMUNOGENICITY OF TWO SARS-COV-2 ADJUVANTED RECOMBINANT PROTEIN VACCINES (MONOVALENT AND BIVALENT) WERE TESTED AS PRIMARY SERIES AND MONOVALENT BOOSTER DOSE AS AN EXTENSION. IVI LED THE EFFORT IN NEPAL TO CONDUCT THE CLINICAL TRIAL INCLUDING CONDUCTING THE LOCAL DSMB MEETING. THE PRIMARY SERIES STUDY WAS INITIATED IN JULY 2021. THE FIRST SUBJECT FOR THE PRIMARY SERIES WAS ENROLLED IN SEPTEMBER 2021. THE CROSSOVER/BOOSTER PHASE STARTED IN JANUARY 2023. THE LAST SUBJECT VACCINATION FOR THE CROSSOVER/BOOSTER PHASE WAS COMPLETED IN NOVEMBER 2023. INVESTIGATORS MEETING WAS CONDUCTED IN FEBRUARY 2023 FOR THE SUCCESSFUL CONDUCTION OF THE PRIMARY SERIES STUDY. THE 11TH DSMB MEETING WAS HELD ON SEPTEMBER 2023, AND NO SAFETY CONCERN WAS RAISED. IVI TEAM CONDUCTED A QUALITY CONTROL VISIT IN Q3 2023. FINAL QUALITY CONTROL VISIT TO SITES WAS DONE IN Q2 2024. STUDY SITE CLOSE-OUT WAS ACTIVITY WAS COMPLETED IN Q3 2024. STUDY DOCUMENT ARCHIVING PROCESS WAS DONE IN Q3 2024. FINAL DATABASE LOCK WAS DONE IN Q3 2024. FINAL DSMB PREPARATION WAS COMPLETED AT THE END OF 2024, AND MEETING WAS CONDUCTED IN JANUARY 2025. NO SAFETY CONCERNS WERE RAISED. 53856951 25821042 0 ALL OTHER PROGRAMS 53856951 25821042 59425409 true true false false false false false false false false true false false false true false true false false true true true false false true false false true false true false false false false false false false false false false false false false false false false false false false false true X 0 0 260 true false true KS false false false false false false false false false false X 20 19 false false false false false true false true true false true true false true true true true true true true false false X SEUNGHWA CHEON 8228811167 1 GWANAK-RO GWANAK-GU SEOUL KS JEROME KIM DIRECTOR GENERAL 40.0 X X 756439 0 157292 ANTHONY FORD-HUTCHINSON DIRECTOR / BOARD OF TRUSTEE 1.0 X 1500 0 0 CATHARINA MAIJGREN STEFFENSSO DIRECTOR / BOARD OF TRUSTEE 1.0 X 0 0 0 CHRISTIAN W MANDL DIRECTOR / BOARD OF TRUSTEE 1.0 X 1500 0 0 CHUL LEE DIRECTOR / BOARD OF TRUSTEE 1.0 X 0 0 0 DEBORAH BIRX DIRECTOR / BOARD OF TRUSTEE 1.0 X 0 0 0 EHSANUL KABIR DIRECTOR / BOARD OF TRUSTEE 1.0 X 0 0 0 GEORGE BICKERSTAFF CHAIRPERSON / BOARD OF TRUSTEE 1.0 X 1500 0 0 GI-EUN RHIE DIRECTOR / BOARD OF TRUSTEE 1.0 X 0 0 0 GORDON DOUGAN DIRECTOR / BOARD OF TRUSTEE 1.0 X 1500 0 0 HANNAH NOHYNEK VICE-CHAIRPERSON/BOARD TRUSTEE 1.0 X 1500 0 0 JEAN-MARIE OKWO-BELE DIRECTOR / BOARD OF TRUSTEE 1.0 X 1500 0 0 LEON MUTESA DIRECTOR / BOARD OF TRUSTEE 1.0 X 0 0 0 MARIA PAULKE-KORINEK DIRECTOR / BOARD OF TRUSTEE 1.0 X 0 0 0 NAKORN PREMSRI DIRECTOR / BOARD OF TRUSTEE 1.0 X 0 0 0 OUTI KUIVASNIEMI DIRECTOR / BOARD OF TRUSTEE 1.0 X 0 0 0 RAJIV BAHL DIRECTOR / BOARD OF TRUSTEE 1.0 X 0 0 0 RICHARD HENRIQUES DIRECTOR / BOARD OF TRUSTEE 1.0 X 1500 0 0 YANCHUN LILY LI DIRECTOR / BOARD OF TRUSTEE 1.0 X 1500 0 0 ZIAD AHMED A MEMISH DIRECTOR / BOARD OF TRUSTEE 1.0 X 750 0 0 ANH WARTEL DEPUTY DIRECTOR, GENERAL, EUROPE 40.0 X 338690 0 2808 DOUGLAS N SHAFFER DEPUTY DIRECTOR GENERAL, GLOBAL AFFAIRS 40.0 X 126739 0 386 FLORIAN MARKS DEPUTY DIRECTOR GENERAL, EPIDEMIOLOGY 40.0 X 346625 0 1836 FRANCOIS BELIN CHIEF OPERATING OFFICER 40.0 X 486257 0 1904 HEE SOO KIM DEPUTY DIRECTOR GENERAL, CLINICAL ASSESSMENT 40.0 X 336079 0 3019 JESSICA COWDEN DEPUTY DIRECTOR GENERAL, CLINICAL, ASSESSMENT 40.0 X 123358 0 4631 KYUNG-TAIK HAN DEPUTY DIRECTOR GENERAL, GOVERNMENT RELATIONS 40.0 X 237717 0 603 MANKI SONG DEPUTY DIRECTOR GENERAL, SCIENCE 40.0 X 296976 0 4283 VINCENT CANOUET DEPUTY DIRECTOR GENERAL, STRATEGY 40.0 X 293707 0 1452 BIRKNEH TILAHUN TADESSE ASSOCIATE DIRECTOR GENERAL EPIDEMIOLOGY 40.0 X 252958 0 2745 JOHN D CLEMENS SENIOR SCIENTIFIC ADVISOR 40.0 X 323736 0 41566 JULIA LYNCH PROGRAM DIRECTOR, CHOLERA 40.0 X 295940 0 17219 SUSHANT SAHASTRABUDDHE ASSOCIATE DIRECTOR GENERAL 40.0 X 262350 0 5523 TOBIN GUARNACCI GLOBAL HEAD, QUALITY MANAGEMENT 40.0 X 292070 0 20603 4782391 0 265870 58 false true false 0 73672 12640053 56905445 69619170 0 0 0 0 0 1777568 1777568 0 0 0 0 0 73672 MISCELLANEOUS REVENUE 900099 181030 181030 RENTAL FOR RESEARCH COLLABORATION 900099 56090 56090 RENTAL FOR ANIMAL ROOM 900099 43031 43031 -2709905 0 0 -2709905 -2429754 68966984 0 0 -652186 3531509 3531509 26173049 26173049 3533551 2395681 1137870 17142483 11622281 5520202 1199180 845704 353476 687460 407638 279350 472 242192 149044 93148 287562 166813 120749 95485 8588 86897 4447809 2594757 1853052 0 2370550 2136701 233749 100 915189 505267 403924 5998 2247035 272695 1974340 4306855 3563964 742684 207 962819 761715 171344 29760 1664160 185241 1478919 67401 24701 42700 LAB SUPPLIES 2857068 2733763 123305 OTHER EXPENSES 1392629 1327576 64509 544 TRAINING 65787 15400 50387 REPAIRS AND MAINTENANCE 61152 3322 57830 0 0 0 0 74250925 59425409 14788435 37081 57393380 60602981 25510041 12967866 0 0 531156 602102 24233484 9626999 8246069 14606485 0 0 12300408 11941272 809202 876098 104790256 101596804 5102041 6960074 0 50173 44106 5152214 7004180 X 50192934 47330821 49445108 47261803 99638042 94592624 104790256 101596804 X -5283941 238523 X false true true false X 51411216 52941661 77015644 88351550 69619170 339339241 0 0 51411216 52941661 77015644 88351550 69619170 339339241 151014496 188324745 126251 56420 486502 1740857 1777568 4187598 0 2347736 0 0 6490073 -2429754 6408055 349934894 0 0.53817 0.56892 X Schedule A, Part II, Line 10 Other Income DESCRIPTION - MISCELLANEOUS REVENUE, COLUMN A - 2347736.0, COLUMN B - 0.0, COLUMN C - 0.0, COLUMN D - 6490073.0, COLUMN E - -2429754.0, COLUMN F - 6408055.0; RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1195956 372799 823157 22990200 9248099 13742101 47328 6101 41227 14606485 Federal Income Taxes SECURITY DEPOSIT 44106 44106 74700651 5733667 5733667 68966984 0 0 68966984 79746069 5733667 5733667 74012402 238523 238523 74250925 Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990 FOREIGN EXCHANGE LOSS - 5733667 Schedule D, Part XII, Line 2(d) Other expenses in audited financial statements not in form 990 FOREIGN EXCHANGE LOSS - 5733667 Schedule D, Part XII, Line 4(b) Other expenses in form 990 not in audited financial statements Prior period Grant Reversal - 238523 East Asia and the Pacific 7 30 Program Services,Grantmaking PROGRAM SERVICES 2377231 Europe (Including Iceland and Greenland) 6 16 Program Services,Grantmaking PROGRAM SERVICES 9026801 South Asia 8 28 Program Services,Grantmaking PROGRAM SERVICES 6402688 Sub-Saharan Africa 10 19 Program Services,Grantmaking PROGRAM SERVICES 6187202 South America 15 5 Program Services,Grantmaking PROGRAM SERVICES 455653 North America (Canada & Mexico only) 3 3 Program Services,Grantmaking PROGRAM SERVICES 1371146 Central America and the Caribbean 2 3 Program Services,Grantmaking PROGRAM SERVICES 352328 51 104 0 0 51 104 26173049 0 26173049 Europe (Including Iceland and Greenland) PROGRAM SERVICE 7477381 WIRE Sub-Saharan Africa PROGRAM SERVICE 2348833 WIRE South Asia PROGRAM SERVICE 2107115 WIRE North America (Canada & Mexico only) PROGRAM SERVICE 1152285 WIRE East Asia and the Pacific PROGRAM SERVICE 1003613 WIRE South Asia PROGRAM SERVICE 963061 WIRE South Asia PROGRAM SERVICE 711249 WIRE Sub-Saharan Africa PROGRAM SERVICE 658157 WIRE South Asia PROGRAM SERVICE 626817 WIRE Sub-Saharan Africa PROGRAM SERVICE 530004 WIRE Sub-Saharan Africa PROGRAM SERVICE 465492 WIRE South Asia PROGRAM SERVICE 463692 WIRE South America PROGRAM SERVICE 431919 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 387598 WIRE East Asia and the Pacific PROGRAM SERVICE 377943 WIRE South Asia PROGRAM SERVICE 369436 WIRE Sub-Saharan Africa PROGRAM SERVICE 360245 WIRE Sub-Saharan Africa PROGRAM SERVICE 352458 WIRE Central America and the Caribbean PROGRAM SERVICE 292949 WIRE South Asia PROGRAM SERVICE 292394 WIRE South Asia PROGRAM SERVICE 292337 WIRE South Asia PROGRAM SERVICE 270055 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 259880 WIRE East Asia and the Pacific PROGRAM SERVICE 251854 WIRE South Asia PROGRAM SERVICE 251105 WIRE South Asia PROGRAM SERVICE 230297 WIRE Sub-Saharan Africa PROGRAM SERVICE 217027 WIRE East Asia and the Pacific PROGRAM SERVICE 213965 WIRE South Asia PROGRAM SERVICE 210094 WIRE Sub-Saharan Africa PROGRAM SERVICE 276318 WIRE East Asia and the Pacific PROGRAM SERVICE 177060 WIRE Sub-Saharan Africa PROGRAM SERVICE 175000 WIRE North America (Canada & Mexico only) PROGRAM SERVICE 161239 WIRE Sub-Saharan Africa PROGRAM SERVICE 161000 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 154644 WIRE East Asia and the Pacific PROGRAM SERVICE 153918 WIRE East Asia and the Pacific PROGRAM SERVICE 150000 WIRE East Asia and the Pacific PROGRAM SERVICE 150000 WIRE Sub-Saharan Africa PROGRAM SERVICE 147985 WIRE Sub-Saharan Africa PROGRAM SERVICE 145517 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 127832 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 124300 WIRE South Asia PROGRAM SERVICE 122879 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 120000 WIRE Sub-Saharan Africa PROGRAM SERVICE 119533 WIRE East Asia and the Pacific PROGRAM SERVICE 108065 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 100000 WIRE Sub-Saharan Africa PROGRAM SERVICE 99906 WIRE South Asia PROGRAM SERVICE 95578 WIRE South Asia PROGRAM SERVICE 91462 WIRE South Asia PROGRAM SERVICE 90960 WIRE East Asia and the Pacific PROGRAM SERVICE 78468 WIRE East Asia and the Pacific PROGRAM SERVICE 71571 WIRE East Asia and the Pacific PROGRAM SERVICE 60000 WIRE South Asia PROGRAM SERVICE 60000 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 58182 WIRE North America (Canada & Mexico only) PROGRAM SERVICE 57622 WIRE East Asia and the Pacific PROGRAM SERVICE 56760 WIRE South Asia PROGRAM SERVICE 55210 WIRE East Asia and the Pacific PROGRAM SERVICE 53241 WIRE Central America and the Caribbean PROGRAM SERVICE 50000 WIRE Sub-Saharan Africa PROGRAM SERVICE 50000 WIRE Sub-Saharan Africa PROGRAM SERVICE 50000 WIRE South Asia PROGRAM SERVICE 50000 WIRE South Asia PROGRAM SERVICE 48814 WIRE Sub-Saharan Africa PROGRAM SERVICE 41545 WIRE South Asia PROGRAM SERVICE 41045 WIRE East Asia and the Pacific PROGRAM SERVICE 38328 WIRE South Asia PROGRAM SERVICE 38080 WIRE East Asia and the Pacific PROGRAM SERVICE 37284 WIRE Sub-Saharan Africa PROGRAM SERVICE 34660 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 30000 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 30000 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 29132 WIRE East Asia and the Pacific PROGRAM SERVICE 28965 WIRE Sub-Saharan Africa PROGRAM SERVICE 27513 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 24210 WIRE East Asia and the Pacific PROGRAM SERVICE 20434 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 18426 WIRE East Asia and the Pacific PROGRAM SERVICE 17601 WIRE South Asia PROGRAM SERVICE 17406 WIRE South Asia PROGRAM SERVICE 14010 WIRE East Asia and the Pacific PROGRAM SERVICE 13635 WIRE South America PROGRAM SERVICE 12845 WIRE East Asia and the Pacific PROGRAM SERVICE 12234 WIRE East Asia and the Pacific PROGRAM SERVICE 11398 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 10000 WIRE Central America and the Caribbean PROGRAM SERVICE 9380 WIRE East Asia and the Pacific PROGRAM SERVICE 8548 WIRE South Asia PROGRAM SERVICE 7819 WIRE East Asia and the Pacific PROGRAM SERVICE 7745 WIRE East Asia and the Pacific PROGRAM SERVICE 5842 WIRE South America PROGRAM SERVICE 5703 WIRE East Asia and the Pacific PROGRAM SERVICE 109911 WIRE Europe (Including Iceland and Greenland) PROGRAM SERVICE 72405 WIRE 33 60 false false false false false false Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements CENTRAL AMERICA AND THE CARIBBEAN-Accrual; EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual; SOUTH AMERICA-Accrual; SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual Schedule F, Part V SCHEDULE F, PART I, LINE 2: THE IVI IS LOCATED IN SEOUL, KOREA WHERE ALL THE GRANT FUNDS ARE MANAGED AND EXECUTED. THE IVI HAS IN PLACE A VERY DETAILED AND RIGOROUS SYSTEM OF FINANCIAL MONITORING. THIS SYSTEM, WHICH IS EVALUATED BY INTERNAL FINANCE PERSONNEL THROUGHOUT THE YEAR AND AUDITED EXTERNALLY EVERY YEAR, IS USED IN CONJUNCTION WITH CAREFUL PROJECT DEVELOPMENT AND IMPLEMENTATION TO ENSURE ACCOUNTABILITY AND BUDGETARY MANAGEMENT RESPONSIBILITY. FOR SUBGRANTS, THE IVI HAS A BROAD OVERALL SYSTEM OF REVIEWING AND TRACKING THE USE OF GRANTS, AND MORE SPECIFIC DAY-TO-DAY REVIEW PROCESSES, WHICH INCLUDE THE FOLLOWING: -REVIEWS OF FINANCIAL AND NARRATIVE REPORTS, AUDIT REPORTS, CORRESPONDENCE AND OTHER DOCUMENTATION PROVIDED BY THE GRANTEES -DIRECT COMMUNICATION WITH GRANTEES THROUGH TELEPHONE AND EMAIL FOR QUESTIONS AND TO CHECK ON PROGRESS OF THE PROJECT -ON-SITE VISITS TO THE FIELD SITES TO REVIEW ONE OR MORE ASPECTS OF THE PROJECTS -MONITORING THROUGH AN EXTERNAL AUDIT. A CERTAIN NUMBER OF SUB-GRANTEES ARE SELECTED FOR THE AUDIT EACH YEAR, WHICH IS DONE TO ENSURE FINANCIAL AND EXPENDITURE COMPLIANCE WITH THE RESEARCH AGREEMENT. SPECIAL EVENT 73672 73672 0 0 0 73672 73672 0 true ICON GOV'T & PUBLIC HEALTH SOLUTIONS 31 ARBOR WAY SUITE 100 BLUE BELL PA 19422 541716562 GOV'T 1543955 PROGRAM SERVICE University of North Carolina at Chapel Hill 104 AIRPORT DRIVE CB1270 CHAPEL HILL NC 27599 566001393 501(C)(3) 313078 PROGRAM SERVICE The Trustees of the University of Pennsylvania 3451 WALNUT STREET ROOM 305 PHILADELPHIA PA 19104 231352685 501(C)(3) 301290 PROGRAM SERVICE TEXAS TECH UNIVERSITY HEALTH SCIENCE 3601 4TH ST LUBBOCK TX 794306209 752142549 501(C)(3) 285000 PROGRAM SERVICE REGENTS OF THE UNIVERSITY OF CALIFORNIA 111 FRANKLIN STREET 7TH FL OAKLAND CA 94607 943067788 501(C)(3) 197070 PROGRAM SERVICE EDJEN BIOTECH LLC 641 LEXINGTON AVE 13TH FL NY NY 10022 N/A 165000 PROGRAM SERVICE MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 021142696 041564655 501(C)(3) 161049 PROGRAM SERVICE THE JOHNS HOPKINS UNIVERSITY 3400 N CHARLES STREET BALTIMORE MD 21218 520595110 501(C)(3) 150000 PROGRAM SERVICE PRES & FELLOWS OF HARVARD COLLEGE MASSACHUSETTS HALL CAMBRIDGE MA 02138 042103580 501(C)(3) 139555 PROGRAM SERVICE BRIGHAM AND WOMEN'S HOSPITAL 15 FRANCIS STREET BOSTON MA 02115 550916227 501(C)(3) 125334 PROGRAM SERVICE New York University 105 EAST 17TH ST 4TH FL RM 411 NEW YORK NY 10003 135562308 501(C)(3) 78355 PROGRAM SERVICE UNIVERSITY OF WASHINGTON 1410 NE CAMPUS PARKWAY SEATTLE WA 98195 916001537 170(C)(1) 40000 PROGRAM SERVICE UNIVERSITY OF MARYLAND 7901 REGENTS DRIVE COLLEGE PARK MD 20742 526002033 MARYLAND STATE 39960 PROGRAM SERVICE 12 1 Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds THE IVI IS LOCATED IN SEOUL, KOREA WHERE ALL THE GRANT FUNDS ARE MANAGED AND EXECUTED. THE IVI HAS IN PLACE A VERY DETAILED AND RIGOROUS SYSTEM OF FINANCIAL MONITORING. THIS SYSTEM, WHICH IS EVALUATED BY INTERNAL FINANCE PERSONNEL THROUGHOUT THE YEAR AND AUDITED EXTERNALLY EVERY YEAR, IS USED IN CONJUNCTION WITH CAREFUL PROJECT DEVELOPMENT AND IMPLEMENTATION TO ENSURE ACCOUNTABILITY AND BUDGETARY MANAGEMENT RESPONSIBILITY. FOR SUBGRANTS, THE IVI HAS A BROAD OVERALL SYSTEM OF REVIEWING AND TRACKING THE USE OF GRANTS, AND MORE SPECIFIC DAY-TO-DAY REVIEW PROCESSES, WHICH INCLUDE THE FOLLOWING: -REVIEWS OF FINANCIAL AND NARRATIVE REPORTS, AUDIT REPORTS, CORRESPONDENCE AND OTHER DOCUMENTATION PROVIDED BY THE GRANTEES -DIRECT COMMUNICATION WITH GRANTEES THROUGH TELEPHONE AND EMAIL FOR QUESTIONS AND TO CHECK ON PROGRESS OF THE PROJECT -ON-SITE VISITS TO THE FIELD SITES TO REVIEW ONE OR MORE ASPECTS OF THE PROJECTS -MONITORING THROUGH AN EXTERNAL AUDIT. A CERTAIN NUMBER OF SUB-GRANTEES ARE SELECTED FOR THE AUDIT EACH YEAR, WHICH IS DONE TO ENSURE FINANCIAL AND EXPENDITURE COMPLIANCE WITH THE RESEARCH AGREEMENT. X X X X true true X X X X false false false false false false false false false JEROME KIM DIRECTOR GENERAL 401483 0 70327 0 284629 0 156000 0 1292 0 913731 0 0 0 ANH WARTEL DEPUTY DIRECTOR, GENERAL, EUROPE 267022 0 0 0 71668 0 0 0 2808 0 341498 0 0 0 FLORIAN MARKS DEPUTY DIRECTOR GENERAL, EPIDEMIOLOGY 279637 0 0 0 66988 0 0 0 1836 0 348461 0 0 0 FRANCOIS BELIN CHIEF OPERATING OFFICER 362006 0 0 0 124251 0 0 0 1904 0 488161 0 0 0 HEE SOO KIM DEPUTY DIRECTOR GENERAL, CLINICAL ASSESSMENT 275507 0 0 0 60572 0 1375 0 1644 0 339098 0 0 0 MANKI SONG DEPUTY DIRECTOR GENERAL, SCIENCE 236660 0 0 0 60316 0 2380 0 1903 0 301259 0 0 0 VINCENT CANOUET DEPUTY DIRECTOR GENERAL, STRATEGY 223132 0 0 0 70575 0 0 0 1452 0 295159 0 0 0 KYUNG-TAIK HAN DEPUTY DIRECTOR GENERAL, GOVERNMENT RELATIONS 194084 0 0 0 43633 0 0 0 603 0 238320 0 0 0 SUSHANT SAHASTRABUDDHE ASSOCIATE DIRECTOR GENERAL 177635 0 0 0 84715 0 0 0 5523 0 267873 0 0 0 JULIA LYNCH PROGRAM DIRECTOR, CHOLERA 252001 0 0 0 43939 0 0 0 17219 0 313159 0 0 0 TOBIN GUARNACCI GLOBAL HEAD, QUALITY MANAGEMENT 188325 0 0 0 103745 0 20000 0 603 0 312673 0 0 0 JOHN D CLEMENS SENIOR SCIENTIFIC ADVISOR 249651 0 0 0 74085 0 40000 0 1566 0 365302 0 0 0 BIRKNEH TILAHUN TADESSE ASSOCIATE DIRECTOR GENERAL EPIDEMIOLOGY 157558 0 0 0 95400 0 0 0 2745 0 255703 0 0 0 Schedule J, Part I, Line 1a Travel for companions TRAVEL FOR COMPANION: AFTER 15 MONTHS OF SERVICE, THE INTERNATIONALLY RECRUITED STAFF IS ENTITLED TO HOME LEAVE TRAVEL. THIS ENTITLEMENT IS AN ECONOMY ROUND TRIP BETWEEN DUTY STATION AND HOME BASE FOR STAFF, SPOUSE AND DEPENDENTS UNDER 21. Schedule J, Part I, Line 1a Tax indemnification and gross-up payments TAX INDEMNIFICATION AND GROSS UP PAYMENTS: IN ORDER TO EQUALIZE THE BENEFITS ACCRUED TO INTERNATIONALLY RECRUITED STAFF, IVI COMPENSATES STAFF WHO ARE OBLIGATED TO PAY TAXES ON IVI DERIVED INCOME TO THEIR HOME COUNTRY. ANY TAX SUBSEQUENTLY LEVIED ON THE AMOUNT OF THE REIMBURSEMENT IS NOT REIMBURSED. IN GENERAL, THIS IS TREATED AS TAXABLE COMPENSATION. Schedule J, Part I, Line 1a Housing allowance or residence for personal use HOUSING ALLOWANCE: IVI PROVIDES INTERNATIONALLY RECRUITED STAFF IN KOREA WITH A HOUSING ALLOWANCE UP TO 75% OF A CEILING THAT IS ESTABLISHED AND REVIEWED PERIODICALLY. Schedule J, Part I, Line 1a Personal services PERSONAL SERVICES (I.E. DRIVER): IVI PROVIDES THE DIRECTOR GENERAL WITH A DRIVER WHICH IS INCLUDED IN HIS/HER EMPLOYMENT CONTRACT PACKAGE APPROVED BY THE BOARD OF TRUSTEES. Form 990, Part III, Line 1 IVI IS THE ONLY INTERNATIONAL ORGANIZATION IN THE WORLD EXCLUSIVELY DEDICATED TO DISCOVERING, DEVELOPING AND DELIVERING VACCINES FOR GLOBAL HEALTH. IVI FOCUSES ON VACCINES AGAINST INFECTIOUS DISEASES OF THE MOST IMPOVERISHED. WE AIM TO MAKE VACCINES AVAILABLE AND ACCESSIBLE FOR VULNERABLE POPULATIONS IN DEVELOPING COUNTRIES. WE LIVE IN AN INCREASINGLY GLOBALIZED WORLD WHERE NEW AND EMERGING INFECTIOUS DISEASES CAN BECOME GLOBAL HEALTH THREATS. IVI ALSO FOCUSES ON VACCINES AGAINST INFECTIOUS DISEASES OF MAJOR GLOBAL HEALTH CONCERN. OUR RESEARCH SPANS THE ENTIRE VACCINE SPECTRUM FROM DISCOVERY AND PRECLINICAL DEVELOPMENT IN OUR SEOUL-BASED LABS TO CLINICAL DEVELOPMENT AT FIELD SITES IN DEVELOPING COUNTRIES TO GENERATING SCIENTIFIC EVIDENCE ON THE NEED FOR VACCINATION IN COUNTRIES WHERE VACCINES ARE MOST NEEDED. OUR HEADQUARTERS IN SEOUL HAVE STATE-OF-THE ART LAB FACILITIES, ANIMAL HOUSE, AND RESEARCH TEAMS THAT INCLUDE CLINICAL IMMUNOLOGY, PROCESS DEVELOPMENT, EPIDEMIOLOGY, CLINICAL & REGULATORY, BIOSTATISTICS & DATA MANAGEMENT, AND POLICY & ECONOMIC RESEARCH. OUTSIDE OF SEOUL, WE HAVE A GLOBAL NETWORK OF FIELD SITES IN MORE THAN 20 COUNTRIES IN ASIA, AFRICA, AND THE AMERICAS. WE MANAGE FIELD SITES IN COLLABORATION WITH REGIONAL AND IN-COUNTRY PARTNERS. WE WORK WITH LOCAL PARTNERS TO IMPLEMENT TRANSLATIONAL AND FIELD RESEARCH PROJECTS, AND WE ALSO PROVIDE TRAINING AND TECHNICAL ASSISTANCE. Form 990, Part III, Line 4d Description of other program services (Expenses $ 53,856,951 including grants of $ 25,821,042)(Revenue $ 0) ALL OTHER PROGRAMS Form 990, Part V, Line 2a IVI'S HEADQUARTERS IS BASED IN SEOUL, KOREA. SINCE THE ORGANIZATION IS NOT UNITED STATES BASED, THE ORGANIZATION HAS ONLY FILED (3) FORM W-2S FOR EMPLOYEES RESIDING IN THE UNITED STATES. AS OF DECEMBER 31, 2024, THE ORGANIZATION REPORTS 260 EMPLOYEES. Form 990, Part V, Line 4a IVI IS A FOREIGN ORGANIZATION. IT IS NOT REQUIRED TO FILE FORM FINCEN 114 (REPORT OF FOREIGN BANK AND FINANCIAL ACCOUNTS). Form 990, Part VI, Line 1a THE IVI BOARD HAS DELEGATED THE AUTHORITY TO ACT ON ITS BEHALF TO THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE CONSISTS OF NINE MEMBERS (BOARD CHAIR, BOARD VICE-CHAIR, CHAIRS OF BOARD COMMITTEES, DIRECTOR-GENERAL OF IVI, AND A HOST COUNTRY REPRESENTATIVE), WHICH ALL ARE ON THE GOVERNING BODY. THE SCOPE OF THE COMMITTEE'S AUTHORITY IS TO ACT ON BEHALF OF THE BOARD BETWEEN FULL BOARD MEETINGS AND SUPERVISE THE EXECUTION OF THE BOARD DECISIONS. Form 990, Part VI, Line 7a Members or stockholders electing members of governing body THE DIRECTOR GENERAL OF THE INSTITUTE IS ALSO A VOTING MEMBER OF THE BOARD; THUS, HE/SHE CAN PARTICIPATE IN THE ELECTION OF THE BOARD. Form 990, Part VI, Line 11b Review of form 990 by governing body THE FINANCE TEAM MAKES A FIRST DRAFT OF FORM 990 AND THE RELATED SCHEDULES. HR PROVIDES SPECIFIC INFORMATION ON COMPENSATION AND OTHER TEAMS PROVIDE FUNDRAISING, GOVERNANCE AND MANAGEMENT INFORMATION. PUBLIC ACCOUNTANT PREPARES THE RETURN ON IVI'S BEHALF AND THIS IS REVIEWED IN TURN BY THE COO AND HEAD OF FINANCE FOR ACCURACY. Form 990, Part VI, Line 12c Conflict of interest policy THE IVI HR PROVIDES A COPY OF THE CONFLICT OF INTEREST POLICY TO ALL DIRECTORS, OFFICERS AND STAFF TO REVIEW AND COMPLETE A DECLARATION OF CONFLICT OF INTEREST ANNUALLY. IN CONNECTION WITH ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST, EACH INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF HIS OR HER SIGNIFICANT FINANCIAL INTERESTS, SIGNIFICANT EQUITY INTERESTS, INTELLECTUAL PROPERTY INTERESTS OR OUTSIDE INTERESTS TO THE CONFLICT COORDINATOR (DIRECTOR GENERAL) WHO MAY CREATE A CONFLICT COMMITTEE COMPOSED OF THREE OTHER MEMBERS OF THE IVI STAFF TO REVIEW CONFLICT OF INTEREST ISSUES THAT MAY ARISE. THE CONFLICT COMMITTEE SHALL BE RESPONSIBLE FOR ENSURING THAT RELEVANT CONFLICTS OF INTEREST, AND THE PROCEDURES TAKEN TO ELIMINATE, REDUCE OR MANAGE THOSE CONFLICTS, ARE DISCLOSED AT OR PRIOR TO ANY BOARD OF TRUSTEES MEETING. THE COMMITTEE SHALL KEEP A RECORD OF ALL ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AND REPORT ANNUALLY THEREON TO THE BOARD OF TRUSTEES. IN CASE OF TRUSTEES, IVI BOARD SECRETARIAT PROVIDES A COPY OF THE CONFLICT OF INTEREST POLICY TO THE MEMBERS WHEN THEY FIRST JOIN, ALL MEMBERS MUST SUBMIT A SIGNED COPY OF THE DISCLOSURE OF ACTUAL AND POTENTIAL CONFLICTS OF INTEREST TO IVI. THE MEMBERS SHOULD REPORT THEIR CHANGES OF STATUS TO THE BOARD SECRETARIAT. Form 990, Part VI, Line 15a Process to establish compensation of top management official THE IVI UNDERTAKES A COMPREHENSIVE COMPENSATION STUDY FOR ITS TOP MANAGEMENT OFFICIAL. A COMPENSATION CONSULTANT CONDUCTS THE STUDY AND LOOKS AT COMPENSATION AMONG COMPARABLE ORGANIZATIONS WITH SIMILAR POSITIONS AND RESPONSIBILITIES IN ORDER TO PROVIDE MARKET DATA TO DETERMINE IVI STAFF MEMBER COMPENSATION. COMPENSATION IS SET BY INDEPENDENT PERSONS, AND CONTEMPORANEOUS DOCUMENTATION OF THE PROCESS IS RETAINED. Form 990, Part VI, Line 15b Process to establish compensation of other employees THE IVI UNDERTAKES A COMPREHENSIVE COMPENSATION STUDY FOR ALL OTHER OFFICERS. A COMPENSATION CONSULTANT CONDUCTS THE STUDY AND LOOKS AT COMPENSATION AMONG COMPARABLE ORGANIZATIONS WITH SIMILAR POSITIONS AND RESPONSIBILITIES IN ORDER TO PROVIDE MARKET DATA TO DETERMINE IVI STAFF MEMBER COMPENSATION. COMPENSATION IS SET BY INDEPENDENT PERSONS, AND CONTEMPORANEOUS DOCUMENTATION OF THE PROCESS IS RETAINED. Form 990, Part VI, Line 19 Required documents available to the public THE IVI'S GOVERNING DOCUMENTS ESTABLISHMENT AGREEMENT, HEADQUARTERS AGREEMENT, CONSTITUTION AND AMENDMENTS TO THE CONSTITUTION ARE AVAILABLE ON IVI'S WEBSITE. THE SUMMARY OF FINANCIAL REPORT IS INCLUDED IN IVI'S ANNUAL REPORT. THE AUDIT REPORT IS ALSO SHARED ON IVI'S WEBSITE. Form 990, Part VIII, Line 11d Other Miscellaneous Revenue FOREIGN EXCHANGE LOSS - Total Revenue: -2709905, Related or Exempt Function Revenue: , Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: -2709905; Form 990, Part XI, Line 9 Other changes in net assets or fund balances PRIOR YEAR GRANT REVERSAL - 238523; Total - 238523;